Knockout of PAD4 or use of PAD4 inhibitor GSK484 will inhibit heparin-induced thrombocytopenia/thrombosis (HIT) thrombocytopenia and thrombosis (Perdomo et al., 2019). The gene discussed is PADI4; the disease is deep vein thrombosis.